Menu
GeneBe

CRP

C-reactive protein, the group of Short pentraxins

Basic information

Region (hg38): 1:159712288-159714589

Links

ENSG00000132693NCBI:1401OMIM:123260HGNC:2367Uniprot:P02741AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CRP gene.

  • Inborn genetic diseases (6 variants)
  • not provided (5 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRP gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
clinvar
4
missense
5
clinvar
1
clinvar
6
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 5 4 2

Variants in CRP

This is a list of pathogenic ClinVar variants found in the CRP region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-159712443-C-T Inflammation Uncertain significance (-)1692995
1-159713554-C-T not specified Uncertain significance (Jan 26, 2022)2273412
1-159713564-C-A Likely benign (Jun 13, 2018)752112
1-159713565-A-G not specified Likely benign (Dec 20, 2021)2232682
1-159713581-C-G not specified Uncertain significance (Apr 27, 2022)2403499
1-159713624-G-C not specified Uncertain significance (Mar 27, 2023)2529865
1-159713679-A-G CRP-related disorder Uncertain significance (Nov 22, 2023)3043076
1-159713704-C-T not specified Uncertain significance (Jul 14, 2022)2259287
1-159713840-G-A Likely benign (Aug 22, 2018)726464
1-159713843-C-G CRP-related disorder Uncertain significance (Feb 01, 2024)3061216
1-159713861-G-A Likely benign (Jun 01, 2022)2639485
1-159713898-A-G not specified Uncertain significance (Aug 16, 2022)3077627
1-159713988-G-A not specified Uncertain significance (Oct 05, 2023)3077626
1-159713988-G-C not specified Uncertain significance (Jul 12, 2022)2300884
1-159714024-G-A CRP-related disorder Likely benign (Mar 27, 2023)1049406
1-159714051-G-C not specified Uncertain significance (Dec 17, 2023)3077625
1-159714071-C-T Benign (Jul 11, 2018)791614
1-159714095-A-C Benign (Jul 07, 2018)709552

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CRPprotein_codingprotein_codingENST00000255030 22301
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.003700.416125742051257470.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2521291211.060.000006631462
Missense in Polyphen3644.0950.81643592
Synonymous-0.9666152.11.170.00000328444
Loss of Function-0.53832.151.409.22e-824

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.000.00
East Asian0.00005530.0000544
Finnish0.000.00
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.00005530.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Displays several functions associated with host defense: it promotes agglutination, bacterial capsular swelling, phagocytosis and complement fixation through its calcium-dependent binding to phosphorylcholine. Can interact with DNA and histones and may scavenge nuclear material released from damaged circulating cells.;
Pathway
Selenium Micronutrient Network;Vitamin B12 Metabolism;Folate Metabolism;Human Complement System;Overview of nanoparticle effects;IL-6 signaling pathway;Innate Immune System;Immune System;Initial triggering of complement;Classical antibody-mediated complement activation;Creation of C4 and C2 activators;Complement cascade;Leptin;IL6-mediated signaling events (Consensus)

Recessive Scores

pRec
0.443

Intolerance Scores

loftool
0.712
rvis_EVS
-0.12
rvis_percentile_EVS
44.89

Haploinsufficiency Scores

pHI
0.0484
hipred
N
hipred_score
0.180
ghis
0.407

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.395

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Crp
Phenotype
homeostasis/metabolism phenotype; immune system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Gene ontology

Biological process
acute-phase response;inflammatory response;complement activation, classical pathway;opsonization;positive regulation of gene expression;negative regulation of macrophage derived foam cell differentiation;negative regulation of lipid storage;positive regulation of superoxide anion generation;innate immune response;defense response to Gram-positive bacterium;negative regulation of blood vessel diameter;regulation of interleukin-8 secretion
Cellular component
extracellular region;extracellular space
Molecular function
complement component C1q binding;calcium ion binding;protein binding;low-density lipoprotein particle binding;choline binding;identical protein binding;virion binding;low-density lipoprotein particle receptor binding